1.Nieuwkamp, D. J., et al., Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. Journal of Neurology, 2000. 247(2): p. 117–121.
2.Gao, F., et al., Hydrocephalus after Intraventricular Hemorrhage: The Role of Thrombin. Journal of Cerebral Blood Flow & Metabolism, 2013. 34(3): p. 489–494.
3.Hao, X. D., et al., Thrombin disrupts vascular endothelial‐cadherin and leads to hydrocephalus via protease‐activated receptors‐1 pathway. CNS Neuroscience & Therapeutics, 2019.
4.Bering, E. A. and O. Sato, Hydrocephalus: changes in formation and absorption of cerebrospinal fluid within the cerebral ventricles. Journal of neurosurgery, 1963. 20(12): p. 1050–1063.
5.Orešković, D. and M. Klarica, Development of hydrocephalus and classical hypothesis of cerebrospinal fluid hydrodynamics: facts and illusions. Progress in neurobiology, 2011. 94(3): p. 238–258.
6.Klebe, D., et al., Dabigatran ameliorates post-haemorrhagic hydrocephalus development after germinal matrix haemorrhage in neonatal rat pups. Journal of Cerebral Blood Flow & Metabolism, 2016. 37(9): p. 3135–3149.
7.Yan, J., et al., Role of SCH79797 in Maintaining Vascular Integrity in Rat Model of Subarachnoid Hemorrhage. Stroke, 2013. 44(5): p. 1410–1417.
8.Goldim, M. P., et al., Oxidative stress in the choroid plexus contributes to blood–cerebrospinal fluid barrier disruption during sepsis development. Microvascular Research, 2019. 123: p. 19–24.
9.Karimy, J. K., et al., Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus. Nature Medicine, 2017. 23(8): p. 997–1003.
10.Botfield, H., et al., Decorin prevents the development of juvenile communicating hydrocephalus. Brain, 2013. 136(9): p. 2842–2858.
11.Li, T., et al., Thrombin-induced TGF-beta1 pathway: a cause of communicating hydrocephalus post subarachnoid hemorrhage. Int J Mol Med, 2013. 31(3): p. 660–6.
12.Hofmann, S., et al., The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression. European journal of medical research, 2002. 7(4): p. 171–176.
13.Tan, Q., et al., Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage. Brain Research, 2017. 1654: p. 24–33.
14.Feng, Z., et al., Intraventricular administration of urokinase as a novel therapeutic approach for communicating hydrocephalus. Translational Research, 2017. 180: p. 77–90.e2.
15.Goldmann, T., et al., Origin, fate and dynamics of macrophages at central nervous system interfaces. Nature Immunology, 2016. 17: p. 797.
16.Li, Q. and B. A. Barres, Microglia and macrophages in brain homeostasis and disease. Nature Reviews Immunology, 2018. 18(4): p. 225.
17.Samad, F. and W. Ruf, Inflammation, obesity, and thrombosis. Blood, 2013. 122(20): p. 3415–3422.
18.Kivisäkk, P., et al., Human cerebrospinal fluid central memory CD4+T cells: Evidence for trafficking through choroid plexus and meninges via P-selectin. Proceedings of the National Academy of Sciences, 2003. 100(14): p. 8389–8394.
19.Zhou, F., et al., Hydrocephalus Secondary to Chronic Meningitis. CNS Neuroscience & Therapeutics, 2014. 20(3): p. 296–297.
20.Lattke, M., et al., Nuclear Factor κB Activation Impairs Ependymal Ciliogenesis and Links Neuroinflammation to Hydrocephalus Formation. The Journal of Neuroscience, 2012. 32(34): p. 11511.
21.Dziedzic, T., Systemic inflammation as a therapeutic target in acute ischemic stroke. Expert Review of Neurotherapeutics, 2015. 15(5): p. 523–531.
22.Chamorro, Á., et al., Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. The Lancet Neurology, 2016. 15(8): p. 869–881.
23.Gu, C., et al., Effects of minocycline on epiplexus macrophage activation, choroid plexus injury and hydrocephalus development in spontaneous hypertensive rats. Journal of Cerebral Blood Flow & Metabolism, 2019: p. 0271678X19836117.
24.Faraco, G., et al., Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. The Journal of clinical investigation, 2016. 126(12): p. 4674–4689.
25.Shechter, R., et al., Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity, 2013. 38(3): p. 555–569.
26.Herz, J., et al., Myeloid Cells in the Central Nervous System. Immunity, 2017. 46(6): p. 943–956.
27.Magliozzi, R., et al., A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Annals of Neurology, 2010. 68(4): p. 477–493.
28.Choi, S. R., et al., Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain, 2012. 135(10): p. 2925–2937.
29.Howell, O. W., et al., Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain, 2011. 134(9): p. 2755–2771.
30.Bevan, R. J., et al., Meningeal inflammation and cortical demyelination in acute multiple sclerosis. Annals of Neurology, 2018. 84(6): p. 829–842.
31.Dragunow, M., Meningeal and choroid plexus cells—Novel drug targets for CNS disorders. Brain research, 2013. 1501: p. 32–55.
32.Sica, A. and A. Mantovani, Macrophage plasticity and polarization: in vivo veritas. The Journal of Clinical Investigation, 2012. 122(3): p. 787–795.
33.Sonar, S. A., et al., IFN-γ promotes transendothelial migration of CD4+ T cells across the blood–brain barrier. Immunology & Cell Biology, 2017. 95(9): p. 843–853.
34.Cromer, W. E., et al., The effects of inflammatory cytokines on lymphatic endothelial barrier function. Angiogenesis, 2014. 17(2): p. 395–406.
35.Mehmet Yasar, K., et al., Detection of soluble intercellular adhesion molecule—1 and vascular cell adhesion molecule—1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery, 2004. 101(6): p. 1030–1036.
36.Hubbard, A. K. and R. Rothlein, Intercellular adhesion molecule–1 (ICAM–1) expression and cell signaling cascades. Free Radical Biology and Medicine, 2000. 28(9): p. 1379–1386.
37.Yan, M., et al., Endothelial cell SHP–2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM–1–VE-cadherin interaction. The FASEB Journal, 2017. 31(11): p. 4759–4769.
38.Liu, G., et al., ICAM–1–activated Src and eNOS signaling increase endothelial cell surface PECAM–1 adhesivity and neutrophil transmigration. Blood, 2012. 120(9): p. 1942.
39.Sills, A. K., Jr., et al., Endothelial Cell Expression of Intercellular Adhesion Molecule 1 in Experimental Posthemorrhagic Vasospasm. Neurosurgery, 1997. 41(2): p. 453–461.
40.Gallia, G. L. and R. J. Tamargo, Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurological Research, 2006. 28(7): p. 750–758.
41.Revuelta, M., et al., Characterization of Gene Expression in the Rat Brainstem After Neonatal Hypoxic–Ischemic Injury and Antioxidant Treatment. Molecular Neurobiology, 2017. 54(2): p. 1129–1143.
42.Coughlin, S. R., Thrombin signalling and protease-activated receptors. Nature, 2000. 407(6801): p. 258.
43.Manaenko, A., et al., PAR–1 antagonist SCH79797 ameliorates apoptosis following surgical brain injury through inhibition of ASK1-JNK in rats. Neurobiology of disease, 2013. 50: p. 13–20.
44.Lee, P. R., et al., Protease-activated receptor–1 activation by granzyme B causes neurotoxicity that is augmented by interleukin–1β. Journal of neuroinflammation, 2017. 14(1): p. 131.
45.Yoon, H., et al., Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity. Journal of neurochemistry, 2013. 127(2): p. 283–298.